Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease.
D001855:Bone Marrow Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D003168:Complement Fixation Tests; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D013997:Time Factors
D003561:Cytarabine